Evotec Se Adr (EVO)

Oct 27, 2025

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner - Benzinga

Oct 27, 2025

Oct 13, 2025

ETFs Investing in Evotec SE Sponsored ADR Stocks - TradingView

Oct 13, 2025

Oct 07, 2025

Evotec (NASDAQ:EVO) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Survey - Defense World

Oct 07, 2025

Sep 07, 2025

Evotec Ag’s Earnings Call: Mixed Sentiments and Strategic Moves - MSN

Sep 07, 2025

Sep 03, 2025

Annual General Meeting - Evotec

Sep 03, 2025

Aug 28, 2025

Stock Information - Evotec

Aug 28, 2025

Aug 14, 2025

Evotec SE ADR earnings missed by $0.07, revenue fell short of estimates - Investing.com South Africa

Aug 14, 2025

Aug 14, 2025

Evotec AG Reports Mixed H1 2025 Performance - TipRanks

Aug 14, 2025

Aug 11, 2025

Ørsted announces plan for a rights issue with support from the Danish State as majority shareholder and gross proceeds of DKK 60 billion11.08.25NewsARIVA.DE - rova

Aug 11, 2025

Aug 02, 2025

Evotec shares drop sharply after lowering 2025 revenue forecast - MSN

Aug 02, 2025

Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site By Investing.com - Investing.com South Africa

Jul 30, 2025

Jul 30, 2025

Evotec and Sandoz plan potential sale of Toulouse biologics site - Investing.com

Jul 30, 2025

Jul 26, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

Jul 26, 2025

Jul 25, 2025

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union - Ariva

Jul 25, 2025

Jul 22, 2025

SAP Quarterly Statement Q2 202522.07.25News - Ariva

Jul 22, 2025

Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance - Investing.com Australia

Jul 21, 2025

Jul 21, 2025

Evotec stock tumbles after slashing 2025 revenue guidance By Investing.com - Investing.com Canada

Jul 21, 2025

Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025

May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025

May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025

May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025

May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025

Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com India

Apr 24, 2025

Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com

Apr 18, 2025

Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025

Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025

Apr 08, 2025

Bayer, BioNxt Solutions, Evotec – falscher Zoll Alarm bei Pharma und Biotech! Welche Aktien lohnen sich? - kapitalerhoehungen.de

Apr 08, 2025

Feb 26, 2025

Evotec SE Sponsored ADR Trade Ideas — NASDAQ:EVO - TradingView

Feb 26, 2025

Dec 29, 2024

Evotec Stock: Some Recovery Has Come, Much More Is Expected (NASDAQ:EVO) - Seeking Alpha

Dec 29, 2024

Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024

Nov 15, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - Baystreet.ca

Nov 15, 2024

Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024

Aug 14, 2024

Earnings call: Evotec SE revises 2024 outlook amid market challenges - Investing.com

Aug 14, 2024

Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar Canada

Aug 13, 2024

Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024

May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com India

May 23, 2024

Apr 25, 2024

Earnings call: Evotec SE meets 2023 guidance, appoints new CEO - Investing.com

Apr 25, 2024

Apr 24, 2024

Evotec: Still A Speculative Buy After A Significant Decline (NASDAQ:EVO) - Seeking Alpha

Apr 24, 2024